SCHEMBL14330524

SCHEMBL14330524

c1ccc(-n2c(-c3ccc(-c4ccc5ccc6c7c(ccc4c57)cc4c6c5ncccc5n4-c4ccccc4)cc3)nc3ccccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.41
▸ ESR2 Q92731 1/20 0.41
▸ GRIA1 P42261 1/20 0.38
▸ CACNG8 Q8WXS5 1/20 0.38
▸ CACNG2 Q9Y698 1/20 0.38
▸ RECQL P46063 1/20 0.36
▸ MAPK10 P53779 3/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAPT P10636 2/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC8 Q9BY41 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14330519 0.98 ESR1 (0.44) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL14329609 0.93 ESR1 (0.47) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL14298069 0.88 ESR1 (0.42) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12731470 0.87 ESR1 (0.44) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL14330510 0.84 COMT (0.31) TOP1
SCHEMBL14330504 0.84 ALDH1A1 (0.33) ALDH1A1CYP2C19TSHRTOP1KDM4E
SCHEMBL13965151 0.83 COMT (0.49) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL14330501 0.83 KDM4E (0.37) ALDH1A1CYP2C19TSHRKDM4EPTGER4
SCHEMBL14330534 0.83 TOP1 (0.34) ALDH1A1CYP2C19TSHRTOP1KDM4E
SCHEMBL14330568 0.82 ESR1 (0.43) ESR1ESR2GRIA1CACNG8CACNG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623521-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-01-07 — — US disclosed
US-8623521-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-01-07 — — US disclosed
US-20120326134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed
US-20120326134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120326134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND DDT, DRD1, HTR3D ESR1 116/4885ESR2 1755/4885GRIA1 1220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback